Alto Neuroscience, Inc.ANRONYSE

Revenue (LTM)

Net Income (LTM)

$-63M

-2.9% YoY

Free Cash Flow

$-52M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	-0↓626.2%	0	-1	-1↓31.7%
Operating Income	-12	-29↓142.1%	-38↓29.5%	-69↓81.5%	-66↑3.3%
Net Income	-9	-28↓201.6%	-36↓31.0%	-61↓69.2%	-63↓2.9%
EBITDA	-9	-27↓202.7%	-35↓26.3%	-69↓98.5%	-66↑4.2%
EPS Diluted	-0.36	-1.08↓200.0%	-1.35↓25.0%	-2.50↓85.2%	-2.19↑12.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	26	48↑88.1%	83↑70.8%	168↑103.8%	176↑4.9%
Total Current Assets	28	49↑77.8%	85↑73.5%	169↑98.3%	178↑4.9%
Total Assets	29	51↑76.6%	87↑70.3%	178↑104.9%	185↑4.0%
Total Current Liabilities	2	6↑207.2%	6↑0.9%	10↑78.4%	11↑13.2%
Total Liabilities	41	89↑116.3%	158↑77.3%	26↓83.5%	34↑28.6%
Total Equity	-12	-38↓207.8%	-72↓86.6%	151↑311.3%	151↓0.2%
Total Debt	38	82↑115.1%	10↓87.8%	17↑69.7%	4↓74.0%
Net Debt	12	34↑171.0%	-73↓314.9%	-151↓108.5%	-172↓13.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-9	-20↓120.2%	-33↓64.0%	-47↓41.8%	-52↓9.2%
Capital Expenditure	-1	-1↓7.6%	-0↑35.8%	-2↓341.5%	-0↑98.8%
Free Cash Flow	-10	-21↓112.5%	-34↓60.6%	-49↓45.9%	-52↓4.6%
Stock-Based Comp	0	2↑676.7%	3↑64.0%	8↑164.0%	8↑6.3%
Net Change in Cash	22	23↑4.3%	34↑51.1%	86↑152.0%	8↓90.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance